CMCristina Gómez Muñoz

Cristina Gómez Muñoz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cristina Gómez Muñoz has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Isidoro Narbona Arias

    Obstetrics and Gynecology Department, Hospital Materno-Infantil, Hospital Regional Universitario Málaga, Avenida Arroyo de los Ángeles S/N, 29011 Málaga, Spain

    4 shared publications
  • Jesús Salvador Jiménez

    Department of Surgical Specialties, Biochemistry and Immunology, University of Malaga, 29010 Malaga, Spain

    4 shared publications
  • Marta Blasco-Alonso

    Department of Surgical Specialties, Biochemistry and Immunology, University of Malaga, 29010 Malaga, Spain

    4 shared publications
  • Susana Monís Rodríguez

    Department of Surgical Specialties, Biochemistry and Immunology, University of Malaga, Universidad de Málaga, Malaga, Spain; Department of Surgical Specialties, Biochemistry and Immunology, University of Malaga Research Group in Maternal-Fetal Medicine Epigenetics Women’s Diseases and Re-Productive Health, 11 Biomedical Research Institute of Malaga (IBIMA), Málaga, Spain; Hospital Regional Universitario de Málaga, Málaga, Spain, Spain

    4 shared publications
  • Jose Ramon Anderica-Herrero

    Obstetrics and Gynecology Department, Hospital Materno-Infantil, Hospital Regional Universitario Málaga, Avenida Arroyo de los Ángeles S/N, 29011 Málaga, Spain

    2 shared publications
  • Marina Fortún Agud

    Obstetrics and Gynecology, Materno‐Infantil Hospital Regional Universitary Málaga, Avenue Arroyo de los Ángeles S/N, 29011 Málaga, Spain, Spain

    2 shared publications

Latest Publications

  • Open Access

    Caesarean Section Refusal Among Pregnant Nigerian Women in Málaga, Spain: A Critical Narrative Review of the Bioethical Challenges

    by Susana Monis-Rodríguez, María Suarez-Arana, Cristina Gomez-Muñoz, Marta Blasco-Alonso, Isidoro Narbona-Arias, Isaac Cohen-Cordia, Jesus S. Jimenez-Lopez

    Cesarean section is a life-saving intervention, yet access to and acceptance of the procedure vary across healthcare systems and cultural contexts. Among pregnant Ni-gerian women, decisions about cesarean delivery may be influenced by perceived sur-gical risks, fear of pain or impaired fertility, previous childbirth experiences, economic and geographic barriers, language differences, communication quality, and expecta-tions related to family, religion, and gender. This critical narrative review examined the literature on refusal or delayed acceptance of medically recommended cesarean deliv-ery and analyzed the associated bioethical challenges. Publications from 2010 to 2023 were identified through a structured search complemented by biomedical and regional sources. Evidence was charted by setting, population, methodological design, influenc-ing factors, and ethical implications. Refusal could not be attributed to a single cultural belief or to Nigerian identity. Rather, it reflected interactions among autonomy, trust in healthcare professionals, ex-planatory models of illness, previous experiences, social relationships, economic con-straints, and maternity-care organization. The principal ethical tension concerns a pregnant woman’s right to informed refusal and bodily integrity, alongside profession-als’ duty to recommend effective treatment and reduce preventable maternal and fetal risks. Evidence from Nigeria, sub-Saharan Africa, migrant populations, and bioethical literature should be treated as contextual rather than as direct evidence of local preva-lence or outcomes. Clinical care should therefore prioritize clear risk communication, qualified interpreters when needed, shared decision-making, assessment of capacity and coercion, respect for valid refusal, and contingency planning for deterioration. Further local research is needed to characterize care contexts without inferring indi-vidual decisions from nationality or origin

  • Open Access

    Prenatal Diagnosis of Peters-Plus Syndrome: A Case Report

    by Marina Fortún Agud, Susana Monís Rodríguez, Isidoro Narbona Arias, José Ramón Andérica Herrero, Cristina Gómez Muñoz, Marta Blasco Alonso, Jesús S. Jiménez López

    Peters-Plus syndrome is a rare autosomal recessive disorder caused by biallelic pathogenic variants in the B3GLCT gene and characterized by multisystem involvement. Fewer than 100 cases have been reported to date, and only a limited number have been diagnosed prenatally. Prenatal identification is challenging due to the variable and non-specific nature of fetal findings and the frequent absence of detectable ocular anomalies during routine ultrasound. We report a prenatal diagnosis of Peters-Plus syndrome in a monochorionic diamniotic twin pregnancy, based on the progressive identification of early-onset intrauterine growth restriction, rhizomelic limb shortening, craniofacial dysmorphism, and mild central nervous system abnormalities. Standard cytogenetic and chromosomal microarray analyses were normal, prompting extended genetic testing. Prenatal exome sequencing identified a homozygous pathogenic splice-site variant (c.660+1G>A) in B3GLCT in both fetuses, confirming the diagnosis. This case highlights the importance of recognizing suggestive multisystem prenatal findings and the crucial role of advanced genetic testing in achieving an accurate prenatal diagnosis. Early molecular confirmation enables appropriate parental counseling regarding prognosis, recurrence risk, and future reproductive options.

  • Open Access

    Prenatal Diagnosis of Peters-Plus Syndrome: A Case Report

    by Fortún Agud Marina, Monís Rodriguez Susana, Narbona Arias Isidoro, Andérica Herrero José Ramón, Gómez Muñoz Cristina, Blasco Alonso Marta, Jimenez Lopez Jesus S

    Peters-Plus syndrome is a rare autosomal recessive disorder characterized by multisystem involvement, with a primary manifestation in the anterior segment of the eye. The hallmark feature, Peters anomaly, presents as central corneal opacity with iridocorneal adhesions. Clinically, patients often exhibit the classic triad of anterior chamber defects, short stature, and brachydactyly, accompanied by craniofacial dysmorphisms such as cleft lip and/or palate, hypertelorism, and short palpebral fissures, as well as variable intellectual disability. Skeletal abnormalities include rhizomelic limb shortening, clinodactyly, and restricted growth, frequently responsive to growth hormone therapy. Additional manifestations may involve congenital heart defects, genitourinary anomalies, and endocrine disturbances such as hypothyroidism. Prenatal growth restriction is common, and structural brain anomalies can occasionally be present, though they do not consistently correlate with neurodevelopmental outcomes. Diagnosis is suspected based on characteristic clinical findings and confirmed through the identification of biallelic pathogenic variants in the B3GLCT gene. Genetic counseling is essential due to the autosomal recessive inheritance pattern. Management is individualized, including early corneal transplantation between 3–6 months to prevent amblyopia, treatment of glaucoma or cataracts, and multidisciplinary follow-up addressing ophthalmologic, endocrine, neurologic and developmental needs. Prognosis varies widely depending on the severity of ocular and systemic involvement. This overview underscores the importance of early recognition, genetic confirmation, and comprehensive, patient-centered care in optimizing outcomes for individuals with Peters-Plus syndrome.

  • Open Access

    More than a Diagnosis: How Prenatal Identification of Cantú Syndrome Transformed a Family’s Medical Narrative

    by Isidoro Narbona-Arias, Marta Blasco-Alonso, Susana Monís-Rodriguez, Cristina Gómez Muñoz, Ernesto González-Mesa, Daniel María Lubián-López, Jesús Jiménez-López

    Background/Objectives: Cantú syndrome is a rare autosomal dominant genetic disorder caused by gain-of-function variants in the ABCC9 or KCNJ8 genes. Although its phenotypic expression is variable and can go unnoticed postnatally, certain ultrasound findings may raise suspicion during pregnancy. This article presents a case of prenatal diagnosis through exome sequencing, which also enabled retrospective diagnosis in the mother and a previously undiagnosed child, highlighting the clinical and emotional value of diagnostic certainty in fetal medicine. Methods: We conducted a descriptive observational study based on a case identified at the Fetal Medicine Unit of the Regional University Hospital of Málaga. The patient underwent high-resolution ultrasound and trio-based exome sequencing (fetus and both parents). Results: Prenatal exome sequencing revealed a heterozygous pathogenic variant in ABCC9, consistent with Cantú syndrome, identified simultaneously in the fetus and the mother as part of a trio-based analysis, confirming maternal inheritance. The same variant was later detected in the patient’s older daughter, who had been under pediatric evaluation for a suggestive phenotype but had not received a genetic diagnosis until this study. The prenatal diagnosis allowed for obstetric and neonatal planning, genetic counselling, and a reinterpretation of the clinical and emotional meaning of previous pregnancies. Conclusions: Prenatal diagnosis of Cantú syndrome enables anticipation of perinatal complications, planned clinical interventions, and also provides emotional relief and a coherent narrative for families. In scenarios of variable phenotypic expressivity, fetal medicine may represent a gateway to family diagnosis, with significant clinical and psychosocial implications.